nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP1A2—Carmustine—lymphatic system cancer	0.13	0.187	CbGbCtD
Cilostazol—CYP3A5—Teniposide—lymphatic system cancer	0.118	0.169	CbGbCtD
Cilostazol—CYP2C19—Teniposide—lymphatic system cancer	0.095	0.136	CbGbCtD
Cilostazol—CYP3A7—Vincristine—lymphatic system cancer	0.0755	0.108	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0755	0.108	CbGbCtD
Cilostazol—CYP3A5—Vincristine—lymphatic system cancer	0.0567	0.0812	CbGbCtD
Cilostazol—CYP3A4—Cytarabine—lymphatic system cancer	0.0466	0.0668	CbGbCtD
Cilostazol—CYP3A4—Teniposide—lymphatic system cancer	0.0459	0.0658	CbGbCtD
Cilostazol—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0321	0.046	CbGbCtD
Cilostazol—CYP3A4—Vincristine—lymphatic system cancer	0.0221	0.0317	CbGbCtD
Cilostazol—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000648	0.00214	CcSEcCtD
Cilostazol—Musculoskeletal stiffness—Methotrexate—lymphatic system cancer	0.000645	0.00213	CcSEcCtD
Cilostazol—Chills—Bleomycin—lymphatic system cancer	0.000645	0.00213	CcSEcCtD
Cilostazol—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00064	0.00212	CcSEcCtD
Cilostazol—Nausea—Mechlorethamine—lymphatic system cancer	0.000638	0.00211	CcSEcCtD
Cilostazol—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.000637	0.00211	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000634	0.0021	CcSEcCtD
Cilostazol—Jaundice—Mitoxantrone—lymphatic system cancer	0.000633	0.00209	CcSEcCtD
Cilostazol—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.000631	0.00209	CcSEcCtD
Cilostazol—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.000631	0.00209	CcSEcCtD
Cilostazol—Haemoglobin—Carmustine—lymphatic system cancer	0.000631	0.00208	CcSEcCtD
Cilostazol—Urticaria—Teniposide—lymphatic system cancer	0.000629	0.00208	CcSEcCtD
Cilostazol—Haemorrhage—Carmustine—lymphatic system cancer	0.000627	0.00207	CcSEcCtD
Cilostazol—Abdominal pain—Teniposide—lymphatic system cancer	0.000626	0.00207	CcSEcCtD
Cilostazol—Body temperature increased—Teniposide—lymphatic system cancer	0.000626	0.00207	CcSEcCtD
Cilostazol—Paraesthesia—Fludarabine—lymphatic system cancer	0.000625	0.00207	CcSEcCtD
Cilostazol—Hypoaesthesia—Carmustine—lymphatic system cancer	0.000624	0.00206	CcSEcCtD
Cilostazol—Hyperuricaemia—Methotrexate—lymphatic system cancer	0.000624	0.00206	CcSEcCtD
Cilostazol—Dyspnoea—Fludarabine—lymphatic system cancer	0.000621	0.00205	CcSEcCtD
Cilostazol—Haematuria—Mitoxantrone—lymphatic system cancer	0.000619	0.00205	CcSEcCtD
Cilostazol—Oedema peripheral—Carmustine—lymphatic system cancer	0.000618	0.00204	CcSEcCtD
Cilostazol—Dyspepsia—Fludarabine—lymphatic system cancer	0.000613	0.00203	CcSEcCtD
Cilostazol—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000609	0.00201	CcSEcCtD
Cilostazol—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000606	0.002	CcSEcCtD
Cilostazol—Decreased appetite—Fludarabine—lymphatic system cancer	0.000605	0.002	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000601	0.00199	CcSEcCtD
Cilostazol—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000596	0.00197	CcSEcCtD
Cilostazol—Pain—Fludarabine—lymphatic system cancer	0.000596	0.00197	CcSEcCtD
Cilostazol—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.000589	0.00195	CcSEcCtD
Cilostazol—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000586	0.00194	CcSEcCtD
Cilostazol—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000585	0.00193	CcSEcCtD
Cilostazol—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000583	0.00193	CcSEcCtD
Cilostazol—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00058	0.00192	CcSEcCtD
Cilostazol—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000579	0.00191	CcSEcCtD
Cilostazol—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.000579	0.00191	CcSEcCtD
Cilostazol—Anaemia—Bleomycin—lymphatic system cancer	0.000578	0.00191	CcSEcCtD
Cilostazol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000574	0.0019	CcSEcCtD
Cilostazol—Asthenia—Teniposide—lymphatic system cancer	0.000568	0.00188	CcSEcCtD
Cilostazol—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.000565	0.00187	CcSEcCtD
Cilostazol—Melaena—Methotrexate—lymphatic system cancer	0.000565	0.00187	CcSEcCtD
Cilostazol—Malaise—Bleomycin—lymphatic system cancer	0.000564	0.00186	CcSEcCtD
Cilostazol—Pruritus—Teniposide—lymphatic system cancer	0.000561	0.00185	CcSEcCtD
Cilostazol—Leukopenia—Bleomycin—lymphatic system cancer	0.00056	0.00185	CcSEcCtD
Cilostazol—Cystitis—Methotrexate—lymphatic system cancer	0.000559	0.00185	CcSEcCtD
Cilostazol—Cardiac disorder—Vincristine—lymphatic system cancer	0.000556	0.00184	CcSEcCtD
Cilostazol—Body temperature increased—Fludarabine—lymphatic system cancer	0.000551	0.00182	CcSEcCtD
Cilostazol—Vaginal infection—Methotrexate—lymphatic system cancer	0.000546	0.00181	CcSEcCtD
Cilostazol—Cough—Bleomycin—lymphatic system cancer	0.000546	0.0018	CcSEcCtD
Cilostazol—Angiopathy—Vincristine—lymphatic system cancer	0.000543	0.0018	CcSEcCtD
Cilostazol—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000543	0.0018	CcSEcCtD
Cilostazol—Diarrhoea—Teniposide—lymphatic system cancer	0.000542	0.00179	CcSEcCtD
Cilostazol—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00054	0.00178	CcSEcCtD
Cilostazol—Chest pain—Bleomycin—lymphatic system cancer	0.000533	0.00176	CcSEcCtD
Cilostazol—Myalgia—Bleomycin—lymphatic system cancer	0.000533	0.00176	CcSEcCtD
Cilostazol—Back pain—Carmustine—lymphatic system cancer	0.000528	0.00175	CcSEcCtD
Cilostazol—Discomfort—Bleomycin—lymphatic system cancer	0.000526	0.00174	CcSEcCtD
Cilostazol—Chills—Mitoxantrone—lymphatic system cancer	0.000523	0.00173	CcSEcCtD
Cilostazol—Ecchymosis—Methotrexate—lymphatic system cancer	0.000523	0.00173	CcSEcCtD
Cilostazol—Bladder pain—Methotrexate—lymphatic system cancer	0.000523	0.00173	CcSEcCtD
Cilostazol—Oedema—Bleomycin—lymphatic system cancer	0.000511	0.00169	CcSEcCtD
Cilostazol—Infection—Bleomycin—lymphatic system cancer	0.000507	0.00168	CcSEcCtD
Cilostazol—Anaemia—Carmustine—lymphatic system cancer	0.000505	0.00167	CcSEcCtD
Cilostazol—Back pain—Vincristine—lymphatic system cancer	0.000504	0.00167	CcSEcCtD
Cilostazol—Vomiting—Teniposide—lymphatic system cancer	0.000504	0.00167	CcSEcCtD
Cilostazol—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.0005	0.00165	CcSEcCtD
Cilostazol—Asthenia—Fludarabine—lymphatic system cancer	0.0005	0.00165	CcSEcCtD
Cilostazol—Rash—Teniposide—lymphatic system cancer	0.0005	0.00165	CcSEcCtD
Cilostazol—Dermatitis—Teniposide—lymphatic system cancer	0.000499	0.00165	CcSEcCtD
Cilostazol—Headache—Teniposide—lymphatic system cancer	0.000496	0.00164	CcSEcCtD
Cilostazol—Pruritus—Fludarabine—lymphatic system cancer	0.000493	0.00163	CcSEcCtD
Cilostazol—Back pain—Mitoxantrone—lymphatic system cancer	0.000491	0.00162	CcSEcCtD
Cilostazol—Leukopenia—Carmustine—lymphatic system cancer	0.000489	0.00162	CcSEcCtD
Cilostazol—Anorexia—Bleomycin—lymphatic system cancer	0.000487	0.00161	CcSEcCtD
Cilostazol—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000483	0.0016	CcSEcCtD
Cilostazol—Anaemia—Vincristine—lymphatic system cancer	0.000482	0.00159	CcSEcCtD
Cilostazol—Hypotension—Bleomycin—lymphatic system cancer	0.000477	0.00158	CcSEcCtD
Cilostazol—Diarrhoea—Fludarabine—lymphatic system cancer	0.000476	0.00158	CcSEcCtD
Cilostazol—Hypertension—Carmustine—lymphatic system cancer	0.000471	0.00156	CcSEcCtD
Cilostazol—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000471	0.00156	CcSEcCtD
Cilostazol—Nausea—Teniposide—lymphatic system cancer	0.000471	0.00156	CcSEcCtD
Cilostazol—Anaemia—Mitoxantrone—lymphatic system cancer	0.000469	0.00155	CcSEcCtD
Cilostazol—Vertigo—Vincristine—lymphatic system cancer	0.000468	0.00155	CcSEcCtD
Cilostazol—Leukopenia—Vincristine—lymphatic system cancer	0.000467	0.00154	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000465	0.00154	CcSEcCtD
Cilostazol—Myalgia—Carmustine—lymphatic system cancer	0.000465	0.00154	CcSEcCtD
Cilostazol—Chest pain—Carmustine—lymphatic system cancer	0.000465	0.00154	CcSEcCtD
Cilostazol—Anxiety—Carmustine—lymphatic system cancer	0.000463	0.00153	CcSEcCtD
Cilostazol—Paraesthesia—Bleomycin—lymphatic system cancer	0.000458	0.00152	CcSEcCtD
Cilostazol—Malaise—Mitoxantrone—lymphatic system cancer	0.000458	0.00151	CcSEcCtD
Cilostazol—Dyspnoea—Bleomycin—lymphatic system cancer	0.000455	0.0015	CcSEcCtD
Cilostazol—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000454	0.0015	CcSEcCtD
Cilostazol—Hypertension—Vincristine—lymphatic system cancer	0.00045	0.00149	CcSEcCtD
Cilostazol—Oedema—Carmustine—lymphatic system cancer	0.000446	0.00147	CcSEcCtD
Cilostazol—Decreased appetite—Bleomycin—lymphatic system cancer	0.000444	0.00147	CcSEcCtD
Cilostazol—Myalgia—Vincristine—lymphatic system cancer	0.000444	0.00147	CcSEcCtD
Cilostazol—Cough—Mitoxantrone—lymphatic system cancer	0.000443	0.00146	CcSEcCtD
Cilostazol—Infection—Carmustine—lymphatic system cancer	0.000443	0.00146	CcSEcCtD
Cilostazol—Vomiting—Fludarabine—lymphatic system cancer	0.000443	0.00146	CcSEcCtD
Cilostazol—Rash—Fludarabine—lymphatic system cancer	0.000439	0.00145	CcSEcCtD
Cilostazol—Dermatitis—Fludarabine—lymphatic system cancer	0.000439	0.00145	CcSEcCtD
Cilostazol—Hypertension—Mitoxantrone—lymphatic system cancer	0.000438	0.00145	CcSEcCtD
Cilostazol—Pain—Bleomycin—lymphatic system cancer	0.000437	0.00144	CcSEcCtD
Cilostazol—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000436	0.00144	CcSEcCtD
Cilostazol—Headache—Fludarabine—lymphatic system cancer	0.000436	0.00144	CcSEcCtD
Cilostazol—Tachycardia—Carmustine—lymphatic system cancer	0.000435	0.00144	CcSEcCtD
Cilostazol—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000432	0.00143	CcSEcCtD
Cilostazol—Chest pain—Mitoxantrone—lymphatic system cancer	0.000432	0.00143	CcSEcCtD
Cilostazol—Myalgia—Mitoxantrone—lymphatic system cancer	0.000432	0.00143	CcSEcCtD
Cilostazol—Anxiety—Mitoxantrone—lymphatic system cancer	0.000431	0.00142	CcSEcCtD
Cilostazol—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000429	0.00142	CcSEcCtD
Cilostazol—Discomfort—Mitoxantrone—lymphatic system cancer	0.000427	0.00141	CcSEcCtD
Cilostazol—Oedema—Vincristine—lymphatic system cancer	0.000425	0.00141	CcSEcCtD
Cilostazol—Anorexia—Carmustine—lymphatic system cancer	0.000425	0.0014	CcSEcCtD
Cilostazol—Infection—Vincristine—lymphatic system cancer	0.000423	0.0014	CcSEcCtD
Cilostazol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000421	0.00139	CcSEcCtD
Cilostazol—Nervous system disorder—Vincristine—lymphatic system cancer	0.000417	0.00138	CcSEcCtD
Cilostazol—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000417	0.00138	CcSEcCtD
Cilostazol—Hypotension—Carmustine—lymphatic system cancer	0.000416	0.00138	CcSEcCtD
Cilostazol—Oedema—Mitoxantrone—lymphatic system cancer	0.000414	0.00137	CcSEcCtD
Cilostazol—Nausea—Fludarabine—lymphatic system cancer	0.000414	0.00137	CcSEcCtD
Cilostazol—Infection—Mitoxantrone—lymphatic system cancer	0.000412	0.00136	CcSEcCtD
Cilostazol—Shock—Mitoxantrone—lymphatic system cancer	0.000408	0.00135	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000406	0.00134	CcSEcCtD
Cilostazol—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000406	0.00134	CcSEcCtD
Cilostazol—Urticaria—Bleomycin—lymphatic system cancer	0.000406	0.00134	CcSEcCtD
Cilostazol—Anorexia—Vincristine—lymphatic system cancer	0.000406	0.00134	CcSEcCtD
Cilostazol—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000404	0.00134	CcSEcCtD
Cilostazol—Body temperature increased—Bleomycin—lymphatic system cancer	0.000404	0.00133	CcSEcCtD
Cilostazol—Insomnia—Carmustine—lymphatic system cancer	0.000403	0.00133	CcSEcCtD
Cilostazol—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000402	0.00133	CcSEcCtD
Cilostazol—Paraesthesia—Carmustine—lymphatic system cancer	0.0004	0.00132	CcSEcCtD
Cilostazol—Hypotension—Vincristine—lymphatic system cancer	0.000398	0.00131	CcSEcCtD
Cilostazol—Dyspnoea—Carmustine—lymphatic system cancer	0.000397	0.00131	CcSEcCtD
Cilostazol—Anorexia—Mitoxantrone—lymphatic system cancer	0.000395	0.00131	CcSEcCtD
Cilostazol—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000388	0.00128	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000388	0.00128	CcSEcCtD
Cilostazol—Decreased appetite—Carmustine—lymphatic system cancer	0.000387	0.00128	CcSEcCtD
Cilostazol—Hypotension—Mitoxantrone—lymphatic system cancer	0.000387	0.00128	CcSEcCtD
Cilostazol—Insomnia—Vincristine—lymphatic system cancer	0.000385	0.00127	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000385	0.00127	CcSEcCtD
Cilostazol—Paraesthesia—Vincristine—lymphatic system cancer	0.000382	0.00126	CcSEcCtD
Cilostazol—Pain—Carmustine—lymphatic system cancer	0.000381	0.00126	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000377	0.00125	CcSEcCtD
Cilostazol—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000372	0.00123	CcSEcCtD
Cilostazol—Decreased appetite—Vincristine—lymphatic system cancer	0.00037	0.00122	CcSEcCtD
Cilostazol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000369	0.00122	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000367	0.00121	CcSEcCtD
Cilostazol—Feeling abnormal—Carmustine—lymphatic system cancer	0.000367	0.00121	CcSEcCtD
Cilostazol—Asthenia—Bleomycin—lymphatic system cancer	0.000366	0.00121	CcSEcCtD
Cilostazol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000365	0.00121	CcSEcCtD
Cilostazol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000364	0.0012	CcSEcCtD
Cilostazol—Pain—Vincristine—lymphatic system cancer	0.000364	0.0012	CcSEcCtD
Cilostazol—Asthma—Methotrexate—lymphatic system cancer	0.000363	0.0012	CcSEcCtD
Cilostazol—Pruritus—Bleomycin—lymphatic system cancer	0.000361	0.00119	CcSEcCtD
Cilostazol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00036	0.00119	CcSEcCtD
Cilostazol—Pain—Mitoxantrone—lymphatic system cancer	0.000354	0.00117	CcSEcCtD
Cilostazol—Abdominal pain—Carmustine—lymphatic system cancer	0.000352	0.00116	CcSEcCtD
Cilostazol—Body temperature increased—Carmustine—lymphatic system cancer	0.000352	0.00116	CcSEcCtD
Cilostazol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000348	0.00115	CcSEcCtD
Cilostazol—Pancytopenia—Methotrexate—lymphatic system cancer	0.000345	0.00114	CcSEcCtD
Cilostazol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000341	0.00113	CcSEcCtD
Cilostazol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000339	0.00112	CcSEcCtD
Cilostazol—Abdominal pain—Vincristine—lymphatic system cancer	0.000336	0.00111	CcSEcCtD
Cilostazol—Body temperature increased—Vincristine—lymphatic system cancer	0.000336	0.00111	CcSEcCtD
Cilostazol—Urticaria—Mitoxantrone—lymphatic system cancer	0.000329	0.00109	CcSEcCtD
Cilostazol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000328	0.00108	CcSEcCtD
Cilostazol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000328	0.00108	CcSEcCtD
Cilostazol—Pneumonia—Methotrexate—lymphatic system cancer	0.000326	0.00108	CcSEcCtD
Cilostazol—Vomiting—Bleomycin—lymphatic system cancer	0.000325	0.00107	CcSEcCtD
Cilostazol—Rash—Bleomycin—lymphatic system cancer	0.000322	0.00106	CcSEcCtD
Cilostazol—Dermatitis—Bleomycin—lymphatic system cancer	0.000322	0.00106	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000321	0.00106	CcSEcCtD
Cilostazol—Asthenia—Carmustine—lymphatic system cancer	0.00032	0.00106	CcSEcCtD
Cilostazol—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000315	0.00104	CcSEcCtD
Cilostazol—Haematuria—Methotrexate—lymphatic system cancer	0.000309	0.00102	CcSEcCtD
Cilostazol—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000306	0.00101	CcSEcCtD
Cilostazol—Epistaxis—Methotrexate—lymphatic system cancer	0.000305	0.00101	CcSEcCtD
Cilostazol—Asthenia—Vincristine—lymphatic system cancer	0.000305	0.00101	CcSEcCtD
Cilostazol—Diarrhoea—Carmustine—lymphatic system cancer	0.000305	0.00101	CcSEcCtD
Cilostazol—Nausea—Bleomycin—lymphatic system cancer	0.000303	0.001	CcSEcCtD
Cilostazol—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000302	0.000999	CcSEcCtD
Cilostazol—Asthenia—Mitoxantrone—lymphatic system cancer	0.000297	0.000983	CcSEcCtD
Cilostazol—Dizziness—Carmustine—lymphatic system cancer	0.000295	0.000974	CcSEcCtD
Cilostazol—Haemoglobin—Methotrexate—lymphatic system cancer	0.000292	0.000965	CcSEcCtD
Cilostazol—Diarrhoea—Vincristine—lymphatic system cancer	0.000291	0.000962	CcSEcCtD
Cilostazol—Haemorrhage—Methotrexate—lymphatic system cancer	0.000291	0.000961	CcSEcCtD
Cilostazol—Pharyngitis—Methotrexate—lymphatic system cancer	0.000288	0.000953	CcSEcCtD
Cilostazol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000283	0.000937	CcSEcCtD
Cilostazol—Vomiting—Carmustine—lymphatic system cancer	0.000283	0.000937	CcSEcCtD
Cilostazol—Dizziness—Vincristine—lymphatic system cancer	0.000281	0.00093	CcSEcCtD
Cilostazol—Rash—Carmustine—lymphatic system cancer	0.000281	0.000929	CcSEcCtD
Cilostazol—Dermatitis—Carmustine—lymphatic system cancer	0.000281	0.000928	CcSEcCtD
Cilostazol—Headache—Carmustine—lymphatic system cancer	0.000279	0.000923	CcSEcCtD
Cilostazol—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000275	0.000908	CcSEcCtD
Cilostazol—Tinnitus—Methotrexate—lymphatic system cancer	0.000271	0.000896	CcSEcCtD
Cilostazol—Vomiting—Vincristine—lymphatic system cancer	0.000271	0.000894	CcSEcCtD
Cilostazol—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00027	0.000891	CcSEcCtD
Cilostazol—Rash—Vincristine—lymphatic system cancer	0.000268	0.000887	CcSEcCtD
Cilostazol—Dermatitis—Vincristine—lymphatic system cancer	0.000268	0.000886	CcSEcCtD
Cilostazol—Headache—Vincristine—lymphatic system cancer	0.000267	0.000881	CcSEcCtD
Cilostazol—Nausea—Carmustine—lymphatic system cancer	0.000265	0.000875	CcSEcCtD
Cilostazol—Angiopathy—Methotrexate—lymphatic system cancer	0.000264	0.000871	CcSEcCtD
Cilostazol—Vomiting—Mitoxantrone—lymphatic system cancer	0.000263	0.000871	CcSEcCtD
Cilostazol—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000262	0.000866	CcSEcCtD
Cilostazol—Rash—Mitoxantrone—lymphatic system cancer	0.000261	0.000864	CcSEcCtD
Cilostazol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000261	0.000863	CcSEcCtD
Cilostazol—Chills—Methotrexate—lymphatic system cancer	0.000261	0.000862	CcSEcCtD
Cilostazol—Headache—Mitoxantrone—lymphatic system cancer	0.00026	0.000858	CcSEcCtD
Cilostazol—Nausea—Vincristine—lymphatic system cancer	0.000253	0.000835	CcSEcCtD
Cilostazol—Nausea—Mitoxantrone—lymphatic system cancer	0.000246	0.000814	CcSEcCtD
Cilostazol—Back pain—Methotrexate—lymphatic system cancer	0.000245	0.000809	CcSEcCtD
Cilostazol—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000235	0.000776	CcSEcCtD
Cilostazol—Anaemia—Methotrexate—lymphatic system cancer	0.000234	0.000773	CcSEcCtD
Cilostazol—Malaise—Methotrexate—lymphatic system cancer	0.000228	0.000754	CcSEcCtD
Cilostazol—Vertigo—Methotrexate—lymphatic system cancer	0.000227	0.000751	CcSEcCtD
Cilostazol—Leukopenia—Methotrexate—lymphatic system cancer	0.000226	0.000748	CcSEcCtD
Cilostazol—Cough—Methotrexate—lymphatic system cancer	0.000221	0.00073	CcSEcCtD
Cilostazol—Myalgia—Methotrexate—lymphatic system cancer	0.000215	0.000712	CcSEcCtD
Cilostazol—Chest pain—Methotrexate—lymphatic system cancer	0.000215	0.000712	CcSEcCtD
Cilostazol—Arthralgia—Methotrexate—lymphatic system cancer	0.000215	0.000712	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000214	0.000707	CcSEcCtD
Cilostazol—Discomfort—Methotrexate—lymphatic system cancer	0.000213	0.000703	CcSEcCtD
Cilostazol—Infection—Methotrexate—lymphatic system cancer	0.000205	0.000678	CcSEcCtD
Cilostazol—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000202	0.000669	CcSEcCtD
Cilostazol—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000202	0.000668	CcSEcCtD
Cilostazol—Skin disorder—Methotrexate—lymphatic system cancer	0.000201	0.000663	CcSEcCtD
Cilostazol—Anorexia—Methotrexate—lymphatic system cancer	0.000197	0.00065	CcSEcCtD
Cilostazol—Hypotension—Methotrexate—lymphatic system cancer	0.000193	0.000638	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000188	0.000622	CcSEcCtD
Cilostazol—Insomnia—Methotrexate—lymphatic system cancer	0.000187	0.000617	CcSEcCtD
Cilostazol—Paraesthesia—Methotrexate—lymphatic system cancer	0.000185	0.000613	CcSEcCtD
Cilostazol—Dyspnoea—Methotrexate—lymphatic system cancer	0.000184	0.000608	CcSEcCtD
Cilostazol—Dyspepsia—Methotrexate—lymphatic system cancer	0.000182	0.000601	CcSEcCtD
Cilostazol—Decreased appetite—Methotrexate—lymphatic system cancer	0.000179	0.000593	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000178	0.000589	CcSEcCtD
Cilostazol—Pain—Methotrexate—lymphatic system cancer	0.000177	0.000584	CcSEcCtD
Cilostazol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00017	0.000562	CcSEcCtD
Cilostazol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000169	0.000558	CcSEcCtD
Cilostazol—Urticaria—Methotrexate—lymphatic system cancer	0.000164	0.000542	CcSEcCtD
Cilostazol—Abdominal pain—Methotrexate—lymphatic system cancer	0.000163	0.000539	CcSEcCtD
Cilostazol—Body temperature increased—Methotrexate—lymphatic system cancer	0.000163	0.000539	CcSEcCtD
Cilostazol—Asthenia—Methotrexate—lymphatic system cancer	0.000148	0.00049	CcSEcCtD
Cilostazol—Pruritus—Methotrexate—lymphatic system cancer	0.000146	0.000483	CcSEcCtD
Cilostazol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000141	0.000467	CcSEcCtD
Cilostazol—Dizziness—Methotrexate—lymphatic system cancer	0.000137	0.000451	CcSEcCtD
Cilostazol—Vomiting—Methotrexate—lymphatic system cancer	0.000131	0.000434	CcSEcCtD
Cilostazol—Rash—Methotrexate—lymphatic system cancer	0.00013	0.00043	CcSEcCtD
Cilostazol—Dermatitis—Methotrexate—lymphatic system cancer	0.00013	0.00043	CcSEcCtD
Cilostazol—Headache—Methotrexate—lymphatic system cancer	0.000129	0.000428	CcSEcCtD
Cilostazol—Nausea—Methotrexate—lymphatic system cancer	0.000123	0.000405	CcSEcCtD
